The unified data and AI analytics platform for biotech clinical trials. Riva integrates fragmented trial data and turns it into actionable insights, to drive more predictable operations and unlock hidden therapeutic potential.
Location: United States
Total raised: $15M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 18.03.2026 | Series A | $15M | Amino Coll... |
Mentions in press and media 7
| Date | Title | Description |
| 19.03.2026 | AI Engine Transforms Clinical Trials: Rivia Secures $15M to Revolutionize Drug Development | Rivia secured $15M Series A funding. The company tackles fragmented clinical trial infrastructure. It introduces an AI-driven data engine. This engine unifies vast, disparate trial data. It replaces costly, manual reconciliation. Spreadshee... |
| 19.03.2026 | Rivia Secures $15M to Propel AI-Powered Clinical Trials into New Era | Zurich-based Rivia secured $15 million in Series A funding. This investment propels its AI-driven platform. Rivia tackles clinical trial complexity. Its agentic data engine unifies vast data. It streamlines operations. The company aims to c... |
| 18.03.2026 | Rivia raises $15M Series A to bring clinical trials into the agentic AI era | Clinical trials have become exponentially more complex. Data volume has increased more than 400 percent over the past decade. Biotech and Pharma operators still rely on fragmented spreadsheets and rigid legacy systems. Thousands of human h... |
| 18.03.2026 | Zurich-based Rivia raises €13 million to power complex clinical trials with its agentic data engine | Rivia, a Zurich-based startup specialising in AI-driven analytics and clinical trial data infrastructure for BioTechs, today announced a €13 million ($15 million) Series A to accelerate team growth, scale agentic product development, and ex... |
| 18.03.2026 | Rivia Raises $15M in Series A Funding | Rivia, a Zurich, Switzerland-based provider of a clinical trial data engine and AI platform, raised $15m in Series A funding. The round was led by Earlybird, with participation from Defiant, Speedinvest, Amino Collective, and Nina Capital. ... |
| 18.03.2026 | Rivia raises $15M to fix the broken data infrastructure behind clinical trials | Rivia, the Zurich-based data engine for clinical trial intelligence, today announced a $15 million Series A led by Earlybird, with participation from Defiant and existing investors Speedinvest, Amino Collective, and Nina Capital. Over the p... |
| 12.06.2024 | €3M to bring AI analytics and advanced data infrastructure to clinical trials | Founded by seasoned biopharma experts familiar with the industry's pain points, Rivia focuses on creating user-friendly software tailored to the needs of biotech firms. Rivia addresses a significant inefficiency in the industry: current da... |